# OnCo record paper-clark-haystack-mrd-validation-j-mol-diagn-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-clark-haystack-mrd-validation-j-mol-diagn-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-clark-haystack-mrd-validation-j-mol-diagn-2026" ;
  schema:name "Highly Accurate Detection of Circulating Tumor DNA for Monitoring Minimal Residual Disease in Solid Tumors: Analytical and Clinical Validation of the Haystack MRD Assay"@en ;
  schema:description "The validation of Quest's Haystack blood test for leftover cancer, which reports results as a count of tumour DNA molecules per millilitre of plasma."@en ;
  schema:url <https://onco.cc/key-papers/paper-clark-haystack-mrd-validation-j-mol-diagn-2026/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.jmoldx.2026.07.006>, <https://pubmed.ncbi.nlm.nih.gov/42624249/> ;
  schema:sameAs <https://doi.org/10.1016/j.jmoldx.2026.07.006> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Clark M, Prathapam R, Bramlett KS, et al." ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/haystack-mrd/> ;
  onco:companies <https://onco.cc/companies/haystack-oncology/>, <https://onco.cc/companies/quest-diagnostics/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-subclone-attribution-residual-disease/> .